Vol 10, Supplement 18 (July 2018): Journal of Thoracic Disease

Editorial

Clinical usefulness of the surgical Apgar score for estimating short-term and prognostic outcomes after esophagectomy
Naoya Yoshida, Hideo Baba
Dual antiplatelet therapy post CABG?—perhaps, but… why not a radial artery instead?
Jeremy R. Leonard, Antonino Di Franco, Mario Gaudino
Multidisciplinary team approach for complicated pneumothorax
Atsushi Sano
Oxygenation in post-resuscitation care—how much is too much?
Sebastian Schnaubelt, Hans Domanovits, Alexander Niessner, Patrick Sulzgruber
Adjuvant treatment for EGFR-mutated non-small cell lung cancer: do we have a major breakthrough?
Giandomenico Roviello, Marco Imperatori, Michele Aieta, Francesco Sollitto, Matteo Landriscina
The use of cardiac progenitor cells for transplantation in congenital heart disease and an innovative strategy for activating mitochondrial function in such cells
Jiro Abe, Yuma Yamada, Hideyoshi Harashima
ERAS is 20 years old—now it’s time to standardized the intra-op part of our care
Robert J. Cerfolio
Harmonization study of antibodies and platforms for programmed death ligand 1 immunostaining in non-small cell lung cancer: does shuffling couples settle the troubles?
Jumpei Kashima, Yusuke Okuma
PD-L1 immunohistochemistry in patients with non-small cell lung cancer
Takanobu Jotatsu, Keishi Oda, Kazuhiro Yatera
Is alectinib the new first line therapy in ALK-rearranged advanced non-small cell lung cancer?
Anthonie J. van der Wekken, Klaas Kok, Harry J. M. Groen
Change is in the air: dying to breathe oxygen in acute respiratory distress syndrome?
Pierce Geoghegan, Sean Keane, Ignacio Martin-Loeches
(J)ALEX the great: a new era in the world of ALK inhibitors
Solenn Brosseau, Valérie Gounant, Gérard Zalcman
Recovery of lung function after segmentectomy versus lobectomy for early-stage lung cancer
Tawee Tanvetyanon, Robert J. Keenan
cT2N0 esophageal cancer remains a difficult diagnosis
Jon O. Wee
Timing of high intensity statin for acute coronary syndrome: how earlier initiation makes better?
Choongki Kim, Donghoon Choi
Personalized treatment of malignant mesothelioma—dream or reality?
Anja C. Roden
Sex and mortality associated with coronary artery bypass graft
Vito A. Mannacio, Luigi Mannacio
Female gender and left ventricular dysfunction in myocardial surgical revascularization: the strange couple
Luigi Di Tommaso, Raffaele Giordano, Ettorino Di Tommaso, Gabriele Iannelli
Multi-analyte assays and early detection of common cancers
Robert P. Young, Timothy Christmas, Raewyn J. Hopkins
Brain imaging in early stage non-small cell lung cancer: still a controversial topic?
Janna J. A. O. Schoenmaekers, Anne-Marie C. Dingemans, Lizza E. L. Hendriks
Ventricular arrhythmias and sudden death in patients with Ebstein anomaly: insights from a retrospective cohort study
Victor Waldmann, Paul Khairy
The fundamental problem of confounding by medical operability in retrospective comparisons of surgery versus stereotactic body radiation therapy for early-stage lung cancer
Vivek Verma, Chad G. Rusthoven
NextGen training assessment tools in thoracic surgery
Justin M. Karush, Christopher W. Seder
Invited editorial on “Fissureless fissure-last video-assisted thoracoscopic lobectomy for all lung lobes: a better alternative to decrease the incidence of prolonged air leak?”
Hitoshi Igai, Mitsuhiro Kamiyoshihara, Ryohei Yoshikawa, Fumi Osawa, Tomohiro Yazawa
Immune phenotypes in lung cancer patients with COPD: potential implications for immunotherapy
Roberto Chalela, Joaquim Gea, Esther Barreiro
Video-assisted thoracic surgery (VATS) lobectomy: a matter of competence
Mario Nosotti
Editorial on “upfront surgery as first-line therapy in selected patients with stage IIIA non-small cell lung cancer”
Hongsheng Lin, Kun Qiao
Predictive biomarkers for immune checkpoint inhibitor therapy: we need to keep searching
Mary M. Huerter, Apar Kishor Ganti
ALK inhibitors and checkpoint blockade: a cautionary tale of mixing oil with water?
Malini Patel, Salma K. Jabbour, Jyoti Malhotra
Gender and surgical revascularization: there is a light at the end of the tunnel?
Michele Di Mauro, Antonio Totaro, Massimiliano Foschi, Antonio Maria Calafiore
Standardizing the time-honored wedge resection
Masatsugu Hamaji, So Miyahara, Hyun-Sung Lee, Bryan M. Burt
Robotic versus uniportal video-assisted thoracic surgery for lung cancer
Herbert Thomas Maier, Florian Augustin
Extended-sleeve lobectomy: a technically demanding last-ditch effort in lung sparing surgery for central tumor
Charlotte Cohen, Jean-Philippe Berthet